Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1

About this study

Last updated on

This study is for people with:Urinary Incontinence, Overactive Bladder
Intervention being studied:AbobotulinumtoxinA, AbobotulinumtoxinA, AbobotulinumtoxinA Placebo, AbobotulinumtoxinA Placebo (drug)
Purpose:
Treatment
A study testing a potential treatment for a disease or condition.
Sponsored by:Ipsen
Number of participants:408 participants
Unique study IDNCT02660138

How to apply

Find a study site convenient for you below, then email yourself the contact details and next steps.

Choose a site

Participation requirements

Open toboth females and males
Open to people aged18 to 80 years old

There are 100 locations for this study